Tariffs shouldn't have any effect on NEU for several reasons:
1. Acadia and trofinetide manufacturing for the US market are US-based.
2. By the time 2591 hits the US market it is almost certain NEU will have either been taken over or licensed the drug to BP who have global S&M reach.
3. Under any corporate scenario where tariffs are still in place, US manufacturing and sales will be done by a US subsidiary and US-based CMO.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$16.48 |
Change
-0.290(1.73%) |
Mkt cap ! $2.076B | |||
| Open | High | Low | Value | Volume |
| $16.58 | $16.74 | $16.40 | $9.107M | 549.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 864 | $16.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.50 | 1668 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |